Cargando…
A Novel Immunofluorescence Assay for the Rapid Serological Detection of SARS-CoV-2 Infection
As of April 2021, the COVID-19 pandemic has swept through 213 countries and infected more than 132 million individuals globally, posing an unprecedented threat to human health. There are currently no specific antiviral treatments for COVID-19 and vaccination programmes, whilst promising, remain in t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146438/ https://www.ncbi.nlm.nih.gov/pubmed/33923271 http://dx.doi.org/10.3390/v13050747 |